Suppr超能文献

相似文献

1
Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.
J Am Soc Nephrol. 2010 Apr;21(4):697-704. doi: 10.1681/ASN.2009080861. Epub 2010 Jan 28.
2
Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
BMC Nephrol. 2017 Mar 27;18(1):104. doi: 10.1186/s12882-017-0525-6.
3
Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
Nephrol Dial Transplant. 2012 Jan;27(1):231-4. doi: 10.1093/ndt/gfr285. Epub 2011 May 30.
5
Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
BMC Nephrol. 2016 Mar 31;17:37. doi: 10.1186/s12882-016-0241-7.
8
The natural history of the non-nephrotic membranous nephropathy patient.
Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.
10
Remissions and relapses in idiopathic membranous nephropathy.
Nephrol Dial Transplant. 1992;7 Suppl 1:85-90.

引用本文的文献

1
Identification of early predictors of clinical remission in primary membranous nephropathy: a analysis of the STARMEN trial.
Clin Kidney J. 2025 Aug 13;18(9):sfaf256. doi: 10.1093/ckj/sfaf256. eCollection 2025 Sep.
4
Clinical Outcomes in the Nephrotic Syndrome Study Network: Disease Burden and Treatment Patterns over Time.
Glomerular Dis. 2025 Jun 5;5(1):288-303. doi: 10.1159/000546655. eCollection 2025 Jan-Dec.
5
Impact of Time-To-Treatment on Outcomes in Autoimmune Membranous Nephropathy.
Kidney Int Rep. 2025 Apr 9;10(6):1907-1916. doi: 10.1016/j.ekir.2025.04.005. eCollection 2025 Jun.
6
Risk Factors for Disease Progression for Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN).
Kidney Int Rep. 2025 Mar 24;10(6):1917-1928. doi: 10.1016/j.ekir.2025.03.027. eCollection 2025 Jun.
7
Newer B-cell and plasma-cell targeted treatments for rituximab-resistant patients with membranous nephropathy.
Clin Kidney J. 2025 Mar 21;18(5):sfaf088. doi: 10.1093/ckj/sfaf088. eCollection 2025 May.
8
Case report: Coexistence of optic neuritis and primary anti-PLA2R-positive membranous nephropathy.
BMC Neurol. 2025 Mar 22;25(1):124. doi: 10.1186/s12883-025-04076-w.
10
Pilot Trial of Hydroxychloroquine as Add-On Therapy in Patients With Membranous Nephropathy.
Kidney Int Rep. 2024 Sep 21;9(12):3446-3454. doi: 10.1016/j.ekir.2024.09.016. eCollection 2024 Dec.

本文引用的文献

1
The natural history of the non-nephrotic membranous nephropathy patient.
Clin J Am Soc Nephrol. 2009 Sep;4(9):1417-22. doi: 10.2215/CJN.01330209. Epub 2009 Aug 6.
2
Idiopathic membranous nephropathy: diagnosis and treatment.
Clin J Am Soc Nephrol. 2008 May;3(3):905-19. doi: 10.2215/CJN.04321007. Epub 2008 Jan 30.
4
Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial.
Kidney Int. 2007 May;71(9):924-30. doi: 10.1038/sj.ki.5002215. Epub 2007 Mar 21.
5
Efficacy and safety of 'rescue therapy' with mycophenolate mofetil in resistant primary glomerulonephritis--a multicenter study.
Nephrol Dial Transplant. 2007 May;22(5):1351-60. doi: 10.1093/ndt/gfl805. Epub 2007 Feb 20.
7
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
Am J Kidney Dis. 2005 Dec;46(6):1012-29. doi: 10.1053/j.ajkd.2005.08.020.
8
Management of membranous nephropathy: when and what for treatment.
J Am Soc Nephrol. 2005 May;16(5):1188-94. doi: 10.1681/ASN.2005010028. Epub 2005 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验